Evidence mapPaperPMID 15364185Full record

ArticleLancet (London, England)

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Salim Yusuf, Steven Hawken, Stephanie Ounpuu, Tony Dans, Alvaro Avezum, Fernando Lanas, Matthew McQueen, Andrzej Budaj, Prem Pais, John Varigos and 2 more

23 registry-linked trialsOpen access · hybridAbstract readComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Article in Lancet (London, England). The graph could read no effect estimate from its abstract, so it casts no vote on the map. It reports registered trial NCT01321255. Cited by 3,819 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3,819citing papers in PubMed, 7 pooled it
199.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01321255 phase3completed

Improving Equitable Acces and Adherence to Secondary Prevention Therapy With a Fixed-Dose Combination Drug

Ran2012Enrolled2,118Registered outcomes6Posted comparisons0ConditionsMyocardial InfarctionArmsFDC, Separately drugs, simvastatin, aspirin and ramipril
Open the trial in the graph
NCT03906539 phase4completed

Effect of Virgin Coconut Oil (VCO) on Cardiometabolic Parameters in Patients With Dyslipidemia: A Randomized, add-on, Placebo-controlled Clinical Trial

Ran2019Enrolled150Registered outcomes11Posted comparisons0ConditionsDyslipidemiasArmsAtorvastatin 10mg, Placebo, Virgin Coconut Oil (VCO)
Open the trial in the graph
NCT00553852 phase3completednot on this map

Evaluation of GH/IGF-I Axis and of Replacement GH Therapy After Bariatric Surgery in Patients With Very Severe Obesity: Relationships With Body Composition

TypeinterventionalSponsorFederico II UniversityRan2007 to 2008Enrolled24ConditionsObesity, GHDArmsRecombinant GH Saizen (Merck-Serono)
NCT01168700 phase4unknown statusnot on this map

A prospective, randomized, double-blind, placebo-controlled trial of the supplementation with kiolic® in patients with diagnosis of metabolic syndrome to improve endothelial function and inflammatory state. "kymes"

TypeinterventionalSponsorUniversidad de SantanderRan2009 to 2010Enrolled46ConditionsMetabolic SyndromeArmsaged garlic extract, Placebo
NCT01741428 nacompletednot on this map

"Hjerteloeftet". Early Interventions to Promote Physical Activity, Dietary Lifestyle Changes and Optimal Medication for Cardiovascular Risk Factor Reduction in Over 3 Years Follow-up.

TypeinterventionalSponsorLHL HelseRan2012 to 2019Enrolled701ConditionsCardiovascular DiseaseArmsIntervention (INT1)
NCT01899001 nacompletednot on this map

Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS

TypeinterventionalSponsorUniversity of PennsylvaniaRan2013Enrolled40ConditionsPolycystic Ovary Syndrome (PCOS)ArmsCognitive Behavioral Therapy, Nutrition Counseling
NCT02373319 nacompletednot on this map

Validity and Effectiveness of a Method for Self-screening of Cardiovascular Risk

TypeinterventionalSponsorParc de Salut MarRan2016 to 2018Enrolled960ConditionsRisk Factor, CardiovascularArmsCV-screening-1 plus personalized, CV-screening-2 plus personalized, CV-screening-1 plus standard, CV-screening-2 plus standard
NCT02591238 phase4completednot on this map

The Protective Effect of Melatonin on Smoke-induced Vascular Injury in Human

TypeinterventionalSponsorPeking Union Medical College HospitalRan2015 to 2015Enrolled68ConditionsSmoking, Vascular System InjuriesArmsnon-smoker oral placebo, non-smoker oral melatonin, smoker oral placebo, smoker oral melatonin
NCT02597127 phase2completednot on this map

A Placebo-controlled, Double-blind, Randomized Trial to Compare the Effect of Different Doses of ALN-PCSSC Given as Single or Multiple Subcutaneous Injections in Subjects With High Cardiovascular Risk and Elevated LDL-C

TypeinterventionalSponsorThe Medicines CompanyRan2016 to 2017Enrolled501ConditionsAtherosclerotic Cardiovascular Disease, Familial Hypercholesterolemia, DiabetesArmsALN-PCSSC, Normal Saline
NCT02847078 naterminatednot on this map

Effects of a Smart Phone Application in the Secondary Clinical Prevention Management for Chinese Patients After Coronary Intervention Treatment: a Randomized Controlled Trial

TypeinterventionalSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityRan2016 to 2017Enrolled86ConditionsCoronary DiseaseArmssmart phone app, A guideline booklet
NCT02989077 unknown statusnot on this map

Risk Profiling for Patients With Isolated or Combined Coronary and Cerebral Ischemia, and Their Current Status of Risk Factors Control

Typeobservational_patient_registrySponsorEgyptian Cerebro-Cardio-Vascular AssociationRan2017 to 2018Enrolled3,000ConditionsIschemia, Myocardial, Risk Factor, Cardiovascular, Ischemia, Cerebral
NCT03720327 nacompletednot on this map

Fitness Intensive Therapy (Get FIT) to Promote Healthy Living in Older Adults

TypeinterventionalSponsorUniversity of California, IrvineRan2019 to 2022Enrolled54ConditionsCardiovascular Diseases, Cardiovascular Risk FactorArmsGet FIT, Get FIT+
NCT03779737 nacompletednot on this map

Muscular Strength and Aerobic Capacity, a Symbiotic Relationship With Birth Weight and Metabolic Risk of Colombian Scholchildren: Study SIMAC

TypeinterventionalSponsorFundación Oftalmológica de Santander Clínica Carlos Ardila LulleRan2016 to 2016Enrolled150ConditionsResistance Training, Cardiovascular Risk, Low Birth WeightArmsMuscular Resistance training, Cardiorespiratory training, Habitual training
NCT03929354 naunknown statusnot on this map

Intensive Lifestyle Modification Programme Versus Standard Care for Risk Factor Reduction and Stroke Prevention in Patients With Asymptomatic Carotid Artery Stenosis. A Prospective Randomised Controlled Trial

TypeinterventionalSponsorWestern Vascular Institute, IrelandRan2018 to 2022Enrolled208ConditionsCarotid StenosisArmsRisk Factors Modification Programme, Standard Care
NCT04189497 completednot on this map

Development of a Prognostic Tool for the Stratification of Cardiovascular Risk in Patients With Ischemic Stroke

TypeobservationalSponsorUniversity of ThessalyRan2019 to 2019Enrolled3,500ConditionsStroke, Ischemic, Cardiovascular Risk Factor, Cardiovascular Diseases, Cardiovascular Morbidity
NCT04425785 nacompletednot on this map

Physical Exercise and Mental Wellbeing Rehabilitation for Acute Stress-induced Takotsubo Cardiomyopathy: The PLEASE Study

TypeinterventionalSponsorUniversity of AberdeenRan2019 to 2023Enrolled76ConditionsTakotsubo CardiomyopathyArmsPhysical Exercise Program, Cognitive Behavioural Therapy
NCT04501198 naunknown statusnot on this map

Moxibustion Combined With Characteristic Lifestyle Intervention of Traditional Chinese Medicine in the Treatment of Abdominal Obesity: A Study Protocol for a Randomized Controlled Trial

TypeinterventionalSponsorHubei Hospital of Traditional Chinese MedicineRan2020 to 2022Enrolled150ConditionsObesityArmsmoxibustion combined with characteristic lifestyle intervention of traditional chinese medicine, Moxibustion combined with lifestyle intervention., lifestyle intervention
NCT04835181 naunknown statusnot on this map

Electroacupuncture Combined With Umbilical Moxibustion on Abdominal Obesity of Yang Deficiency: A Study Protocol for a Randomized Controlled Trial

TypeinterventionalSponsorHubei Hospital of Traditional Chinese MedicineRan2021 to 2022Enrolled68ConditionsObesity, AbdominalArmsElectroacupuncture combined with umbilical moxibustion, Electroacupuncture
NCT05515653 unknown statusnot on this map

Impact of the Genetic Background as a Risk Factor for Atherosclerotic Cardiovascular Disease in the Brazilian Population

TypeobservationalSponsorHospital Alemão Oswaldo CruzRan2022 to 2024Enrolled3,974ConditionsCardiovascular Diseases, Acute MI, Stroke, Peripheral Arterial DiseaseArmsExposure to genetics (polygenic)
NCT06509282 nacompletednot on this map

Efficacy of a Personalized Concurrent Exercise Prescription Guide for Controlling Cardiovascular Risk and Enhancing Physical Fitness in Adults From a Cardiovascular Health Program: A Pilot Randomized Controlled Clinical Trial.

TypeinterventionalSponsorUniversidad San SebastiánRan2023 to 2024Enrolled39ConditionsCardiovascular Syndrome, MetabolicArmsConcurrent training
NCT06674161 not yet recruitingnot on this map

The Impact of Type 2 Diabetes Mellitus on Cardiovascular Events in Saudi Arabia Now and Future

TypeobservationalSponsorKing Faisal Specialist Hospital & Research CenterRan2024 to 2030Enrolled80ConditionsMortality of Patients with CVD, Mortality of Patients with CVD and T2DM, Mortality of Patients with T2DM, Mortality of Patients with Neither
NCT07672054 not yet recruitingnot on this map

Perspectives and Experience of Patients From Minority Ethic Communities on Advice Provided About Diet and Lifestyle Advice in Management of Their Cardiovascular Disease

TypeobservationalSponsorUniversity of NottinghamRan2026 to 2027Enrolled15ConditionsCardio Vascular Disease, Dietary Change, Dietary Behaviors, Diet HabitsArmsExperience of healthcare
NCT07785921 not yet recruitingnot on this map

Cardiovascular Risk Behavior and Readiness for Lifestyle Change After Myocardial Infarction: A Cross-sectional Questionnaire Study (HERZ-AKTIV)

TypeobservationalSponsorKliniken Essen-MitteRan2026 to 2028Enrolled143ConditionsCardiovascular (CV) Risk, Heart Attack Patients
3 · Its place in the literature

Who cites it

3,819 citing papers in PubMed, 7 syntheses or guidelines pooled it, 11,852 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Guideline
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Lipoprotein(a) and premature myocardial infarction: Mechanistic insights and implications for PCI-era residual risk.International journal of cardiology. Cardiovascular risk and prevention · 2026
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

3,759 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Salim YusufPopulation Health Research Institute, Hamilton General Hospital, 237 Barton Street East, Hamilton, Ontario, Canada L8L 2X2. yusufs@mcmaster.ca
Steven Hawken
Stephanie Ounpuu
Tony Dans
Alvaro Avezum
Fernando Lanas
Matthew McQueen
Andrzej Budaj
Prem Pais
John Varigos
Liu Lisheng
INTERHEART Study Investigators
Hamilton General Hospital · CAPopulation Health Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough more than 80% of the global burden of cardiovascular disease occurs in low-income and middle-income countries, knowledge of the importance of risk factors is largely derived from developed countries. Therefore, the effect of such factors on risk of coronary heart disease in most regions of the world is unknown.

methodsWe established a standardised case-control study of acute myocardial infarction in 52 countries, representing every inhabited continent. 15152 cases and 14820 controls were enrolled. The relation of smoking, history of hypertension or diabetes, waist/hip ratio, dietary patterns, physical activity, consumption of alcohol, blood apolipoproteins (Apo), and psychosocial factors to myocardial infarction are reported here. Odds ratios and their 99% CIs for the association of risk factors to myocardial infarction and their population attributable risks (PAR) were calculated.

findingsSmoking (odds ratio 2.87 for current vs never, PAR 35.7% for current and former vs never), raised ApoB/ApoA1 ratio (3.25 for top vs lowest quintile, PAR 49.2% for top four quintiles vs lowest quintile), history of hypertension (1.91, PAR 17.9%), diabetes (2.37, PAR 9.9%), abdominal obesity (1.12 for top vs lowest tertile and 1.62 for middle vs lowest tertile, PAR 20.1% for top two tertiles vs lowest tertile), psychosocial factors (2.67, PAR 32.5%), daily consumption of fruits and vegetables (0.70, PAR 13.7% for lack of daily consumption), regular alcohol consumption (0.91, PAR 6.7%), and regular physical activity (0.86, PAR 12.2%), were all significantly related to acute myocardial infarction (p<0.0001 for all risk factors and p=0.03 for alcohol). These associations were noted in men and women, old and young, and in all regions of the world. Collectively, these nine risk factors accounted for 90% of the PAR in men and 94% in women.

interpretationAbnormal lipids, smoking, hypertension, diabetes, abdominal obesity, psychosocial factors, consumption of fruits, vegetables, and alcohol, and regular physical activity account for most of the risk of myocardial infarction worldwide in both sexes and at all ages in all regions. This finding suggests that approaches to prevention can be based on similar principles worldwide and have the potential to prevent most premature cases of myocardial infarction.

Indexed as

Alcohol DrinkingApolipoproteinsBody ConstitutionCase-Control StudiesCross-Cultural ComparisonDiabetes ComplicationsDietExerciseFemaleGlobal HealthHumansHypertensionMaleMyocardial InfarctionObesityOdds RatioApolipoproteins

Identifiers

PMID15364185
OpenAlexW2155121555

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

and 17 more above

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.